Target intelligence / Profile preview

Ficolin-2 (FCN2)

Target
FCN2
Molecular classification
Pattern recognition receptor, Fibrinogen C domain containing protein, Soluble lectin (innate immune receptor)
01

Overview

Ficolin-2 (FCN2), also known as L-ficolin, is a pattern recognition receptor of the innate immune system, encoded by the FCN2 gene and secreted mainly by the liver into serum. It consists of a collagen-like stalk and a C-terminal fibrinogen-like domain; this multimeric lectin binds specifically to acetylated carbohydrate structures on microbial surfaces such as lipoteichoic acid of Gram-positive bacteria. Upon binding, Ficolin-2 assembles with MBL-associated serine proteases (MASPs), thereby activating the lectin pathway of the complement cascade and promoting opsonization and phagocytosis of pathogens. Ficolin-2 interacts with other humoral molecules (e.g., pentraxin 3) to enhance complement deposition on pathogens. Genetic polymorphisms in FCN2 significantly impact Ficolin-2 serum levels, potentially altering individual susceptibility to infectious diseases.

Other names
EBP-37P35FCNLFicolin-BFicolin-betaHucolinL-ficolinSerum lectin p35Collagen/fibrinogen domain-containing protein 237 kDa elastin-binding protein
02

Mechanism of action

Ligand recognition triggers assembly with MBL-associated serine proteases (MASPs), leading to complement activation and opsonization of pathogens

03

Biological functions

Microbial recognitionInitiation of lectin complement pathwayOpsonizationEnhancement of phagocytosisImmune response (innate immunity)
04

Disease associations

InfectionInflammationPossible links to other immune-related disorders (based on influence on susceptibility to infections via genetic polymorphisms)
05

Safety considerations

Genetic polymorphisms may affect serum levels and susceptibility to infections
06

Biomarkers

Serum FCN2/ficolin-2 levels (patient susceptibility to infection, immune phenotyping)

Beyond the preview

Go deeper on Ficolin-2 (FCN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ficolin-2 (FCN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call